Global Neonatal Intensive Care Respiratory Devices
Market Report
2025
The global neonatal intensive care respiratory devices market size will be USD 1862.8 million in 2025. The rising global prevalence of neonatal respiratory disorders, along with increasing adoption of non-invasive ventilation technologies and growing investments in neonatal intensive care units (NICUs), is projected to propel market revenues to USD 3014.1 million by 2033, with a compound annual growth rate (CAGR) of 6.2% between 2025 and 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Neonatal Intensive Care Respiratory Devices Market Report 2025.
According to Cognitive Market Research, the global neonatal intensive care respiratory devices market size will be USD 1862.8 million in 2025. It will enlarge at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2033.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 1862.8 Million | $ 3014.1 Million | 6.2% |
North America Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 689.2 Million | $ 994.7 Million | 4.7% |
United States Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 543.8 Million | 121212 | 4.5% |
Canada Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 82.7 Million | 121212 | 5.5% |
Mexico Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 62.7 Million | 121212 | 5.2% |
Europe Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 540.2 Million | $ 813.8 Million | 5.3% |
United Kingdom Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 90.8 Million | 121212 | 6.1% |
France Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 49.7 Million | 121212 | 4.5% |
Germany Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 107 Million | 121212 | 5.5% |
Italy Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 46.5 Million | 121212 | 4.7% |
Russia Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 83.7 Million | 121212 | 4.3% |
Spain Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 44.3 Million | 121212 | 4.4% |
Sweden Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 16.7 Million | 121212 | 5.4% |
Denmark Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 11.3 Million | 121212 | 5.1% |
Switzerland Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 8.1 Million | 121212 | 4.9% |
Luxembourg Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 6.5 Million | 121212 | 5.6% |
Rest of Europe Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 75.6 Million | 121212 | 4% |
Asia Pacific Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 447.1 Million | $ 884.6 Million | 8.9% |
China Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 187.8 Million | 121212 | 8.4% |
Japan Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 61.7 Million | 121212 | 7.4% |
South Korea Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 53.6 Million | 121212 | 8% |
India Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 44.7 Million | 121212 | 10.8% |
Australia Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 23.2 Million | 121212 | 8.2% |
Singapore Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 8.9 Million | 121212 | 9.2% |
Taiwan Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 17.4 Million | 121212 | 8.7% |
South East Asia Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 29.5 Million | 121212 | 9.7% |
Rest of APAC Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 20.1 Million | 121212 | 8.7% |
South America Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 70.8 Million | $ 120.6 Million | 6.9% |
Brazil Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 30.3 Million | 121212 | 7.5% |
Argentina Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 11.9 Million | 121212 | 7.8% |
Colombia Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 6.3 Million | 121212 | 6.7% |
Peru Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 5.8 Million | 121212 | 7.1% |
Chile Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 5.1 Million | 121212 | 7.2% |
Rest of South America Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 11.4 Million | 121212 | 6% |
Middle East Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 74.5 Million | $ 132.6 Million | 7.5% |
Qatar Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 6 Million | 121212 | 7% |
Saudi Arabia Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 26.2 Million | 121212 | 7.8% |
Turkey Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 6 Million | 121212 | 8.1% |
UAE Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 15.3 Million | 121212 | 8% |
Egypt Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 4.5 Million | 121212 | 7.3% |
Rest of Middle East Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 16.5 Million | 121212 | 6.7% |
Africa Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 41 Million | $ 67.8 Million | 6.5% |
Nigeria Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 3.3 Million | 121212 | 6.7% |
South Africa Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 14.4 Million | 121212 | 7.4% |
Rest of Africa Neonatal Intensive Care Respiratory Devices Market Sales Revenue | 121212 | $ 23.3 Million | 121212 | 5.7% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Device Type Outlook: |
|
Market Split by End-User Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Neonatal Intensive Care Respiratory Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Neonatal Intensive Care Respiratory Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Neonatal intensive care respiratory devices are specialized medical equipment designed to provide respiratory support to newborns, particularly premature infants, or those with respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), or other pulmonary complications. These devices include neonatal ventilators, continuous positive airway pressure (CPAP) machines, high-frequency oscillatory ventilators, oxygen therapy devices, and humidifiers, among others. They play an important role in maintaining adequate oxygenation and ventilation for neonates requiring intensive medical care. The neonatal intensive care respiratory devices market continues to expand as the incidence of preterm births rises and neonatal respiratory disorders become more prevalent. Moreover, growing investments in healthcare infrastructure, especially in emerging economies, and increasing awareness about neonatal healthcare are further propelling overall market expansion.
In May 2022, Medtronic Plc, a global leader in healthcare technology, announced that the U.S. Food & Drug Administration (FDA) granted 510(k) clearance for the Nellcor™ OxySoft™ neonatal-adult SpO2 sensor. The device is the first pulse oximetry sensor to use a silicone adhesive designed to protect fragile skin and improve repositionability and signal acquisition. This new sensor will help clinicians respond quickly and make well-informed decisions for their critical care patients. https://news.medtronic.com/Nellcor-OxySoft-neonatal-adult-SpO2-sensor
The increasing incidence of preterm births and respiratory disorders such as neonatal respiratory distress syndrome (NRDS) is one of the major drivers behind the expansion of the neonatal intensive care respiratory devices market. According to the World Health Organization (WHO), approximately 15 million babies are born prematurely yearly, representing one in ten babies globally. Preterm birth, defined as birth before 37 weeks of gestation, is a leading cause of death in children under five. Many of them suffer from respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and other breathing-related complications due to underdeveloped lungs. These conditions necessitate the use of modern respiratory support systems such as CPAP devices, high-frequency ventilators, and oxygen therapy equipment to ensure the survival and well-being of neonates.
https://www.who.int/news-room/fact-sheets/detail/preterm-birth
Governments and private healthcare institutions are increasing their investments in neonatal healthcare infrastructure to reduce infant mortality rates and improve newborn care. This market trend is particularly strong in developing economies, where healthcare spending is rising to bridge the gap in advanced neonatal care. Many hospitals are now expanding their NICU facilities, equipping them with modern respiratory devices to cater to the growing market demand. In developed regions such as North America and Europe, healthcare systems are actively focusing on technological inventions, integrating smart respiratory support devices that provide real-time monitoring and AI-driven adjustments for improved neonatal outcomes. The combination of increased funding, infrastructure improvements, and the rising emphasis on neonatal care is accelerating the overall market adoption of innovative respiratory devices in hospitals and specialty care centers worldwide.
The cost of neonatal respiratory devices and the overall care provided in neonatal intensive care units (NICUs) represents a significant barrier to market growth. These devices, such as ventilators, CPAP machines, and oxygen delivery systems, are often complex and specialized and require constant monitoring and maintenance. This results in higher initial purchase costs, as well as ongoing expenses for consumables, repairs, and technical support. For healthcare systems, particularly in low-income and developing countries, this cost can be prohibitive, limiting access to advanced neonatal care and respiratory devices. The higher cost also affects the affordability of hospitals and clinics, especially those in underfunded regions, which can delay or limit the adoption of these life-saving devices.
One of the emerging trends in the neonatal intensive care respiratory devices market is the growing preference for noninvasive respiratory support technologies. Noninvasive devices, such as nasal CPAP (Continuous Positive Airway Pressure) and high-flow nasal cannulas (HFNC), are becoming more widely used in neonatal care due to their ability to deliver effective respiratory support without the need for intubation or mechanical ventilation. These devices are less invasive, reduce the risk of complications like ventilator-associated pneumonia, and promote better comfort for the infant. Non-invasive options are beneficial in managing mild to moderate respiratory distress in preterm neonates, leading to faster recovery times and shorter hospital stays.
The integration of AI and the IoT into neonatal respiratory monitoring systems is another key trend transforming the overall market scope. These technologies enable real-time monitoring, predictive analytics, and automated adjustments, which help healthcare providers manage respiratory conditions more effectively and efficiently. AI-driven respiratory devices can assess neonatal respiratory patterns, analyze data, and provide immediate feedback to clinicians for optimal treatment decisions. IoT-enabled devices allow continuous data collection and remote monitoring, which is particularly beneficial for neonatal care in both hospital settings and home care environments. This technological progression not only improves the accuracy of respiratory interventions but also reduces human error and improves overall patient outcomes.
We have various report editions of Neonatal Intensive Care Respiratory Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The competitive landscape of the global neonatal intensive care respiratory devices market is characterized by the strong presence of several prominent players actively focusing on innovation, product development, and strategic partnerships. Leading companies are increasingly investing in modern technologies to improve neonatal respiratory care, such as non-invasive ventilation solutions, high-frequency oscillatory ventilators, and neonatal CPAP devices.
In July 2023, Drägerwerk AG & Co. KGaA announced that it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Evita V600, V800, and Babylog VN800, its newest devices for mechanical ventilation of adults to premature babies. Dräger has developed an operating concept that makes device orientation easier and provides clear user guidance. https://respiratory-therapy.com/products-treatment/industry-regulatory-news/fda-approvals/fda-clears-three-drager-ventilators/ In May 2023, Sibel Health, Inc. received a new 510(k) clearance from the U.S. FDA for new indications of its ANNE One platform. Its latest clearance is intended for continuous neonatal and infant monitoring for babies born of any gestational age to infants of two years. The ANNE One platform has now received clearance as a clinical-grade continuous monitoring solution suitable for neonates, infants, and adults. It offers several physiological parameters, including heart rate, skin temperature, respiratory rate, body temperature, and apnea-hypopnea index. https://www.medicaldevice-network.com/news/sibel-health-anne-one-platform/?cf-view&cf-closed In April 2023, Motherhood Hospitals by Rhea Healthcare, a specialty hospital chain offering maternity, children, and fertility healthcare services, launched virtual Neonatal Intensive Care Units (NICUs) at five locations in India. Expansion of service portfolio by including innovative treatments assists hospitals in strengthening their market position. https://www.motherhoodindia.com/mediacoverage/indias-motherhood-hospitals-launches-virtual-neonatal-intensive-care-units/
Top Companies Market Share in Neonatal Intensive Care Respiratory Devices Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the global neonatal intensive care respiratory devices market due to its well-established healthcare infrastructure, early adoption of modern neonatal care technologies, and elevated prevalence of preterm births. This region benefits from significant investments in neonatal intensive care units (NICUs), favorable reimbursement policies, and strong government support for neonatal healthcare programs. The U.S. plays a major role in regional dominance, with a high demand for specialized respiratory care devices in hospitals and neonatal care facilities.
The Asia Pacific region is expanding at the fastest CAGR in the neonatal intensive care respiratory devices market due to rising birth rates, increasing incidence of preterm births, and growing awareness about modern neonatal care. Moreover, increasing healthcare expenditures, expanding access to neonatal intensive care units (NICUs), and a surge in demand for cost-effective respiratory support devices are propelling adoption across the region. Countries such as China and India are at the forefront of this growth, supported by a large patient pool and ongoing innovations in medical technology.
The current report Scope analyzes Neonatal Intensive Care Respiratory Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which North America held the majority market share of more than 37% of the global revenue with a market size of USD 689.2 million in 2025 and will prosper at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2033.
According to Cognitive Market Research, the U.S. had a major share in the Neonatal Intensive Care Respiratory Devices market with a market size of USD 543.8 million in 2025 and is predicted to evolve at a CAGR of 4.5% over the analysis period. The growth of the neonatal intensive care respiratory devices market in the U.S. is attributed to the higher prevalence of preterm births and the growing demand for modern healthcare technologies in hospitals.
The Canadian Neonatal Intensive Care Respiratory Devices market had a market share of USD 82.7 million in 2025 and is likely to progress at a CAGR of 5.5% over the estimated period. In Canada, market growth is attributed to the increasing government initiatives to improve healthcare infrastructure and the rising number of neonatal intensive care units (NICUs).
The Mexico Neonatal Intensive Care Respiratory Devices market is likely to register consistent growth at a CAGR of 5.2% within the analysis period, with a market size of USD 62.7 million in 2025.
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which Europe held the second largest market share of more than 29% of the global revenue with a market size of USD 540.2 million in 2025 and will scale at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2033.
The United Kingdom Neonatal Intensive Care Respiratory Devices market had a market share of USD 90.8 million in 2025 and is predicted to surge at a CAGR of 6.1% across the forecasted period. The neonatal respiratory devices market in the U.K. is supported by rising awareness about respiratory conditions in neonates and the development of modern medical devices.
The France Neonatal Intensive Care Respiratory Devices market is anticipated to achieve growth at a CAGR of 4.5% within the forecasting period, with a market size of USD 49.7 million in 2025.
According to Cognitive Market Research, the German Neonatal Intensive Care Respiratory Devices market size was valued at USD 107 million in 2025 and is forecasted to rise at a CAGR of 5.5% throughout the estimation timeframe. The neonatal intensive care respiratory devices market in Germany is witnessing rapid growth attributed to higher neonatal survival focus and increased hospital investments in cutting-edge respiratory technologies.
The Italy Neonatal Intensive Care Respiratory Devices market is predicted to achieve a growth rate at a CAGR of 4.7% within the forecasted period, with a market size of USD 46.5 million in 2025.
The Russian Neonatal Intensive Care Respiratory Devices market is forecasted to witness growth at a CAGR of 4.3% across the anticipated period, with a market size of USD 83.7 million in 2025.
The Spain Neonatal Intensive Care Respiratory Devices market is anticipated to witness growth at a CAGR of 4.4% during the forecasted period, with a market size of USD 44.3 million in 2025.
The Sweden Neonatal Intensive Care Respiratory Devices market is projected to witness gradual growth at a CAGR of 5.4% over the forecasting period, with a market size of USD 16.7 million in 2025.
The Denmark Neonatal Intensive Care Respiratory Devices market is predicted to witness growth at a CAGR of 5.1% throughout the forecasting period, with a market size of USD 11.3 million in 2025.
The Switzerland Neonatal Intensive Care Respiratory Devices market is likely to witness consistent growth at a CAGR of 4.9% over the forecasting period, with a market size of USD 8.1 million in 2025.
The Luxembourg Neonatal Intensive Care Respiratory Devices market is predicted to witness growth at a CAGR of 5.6% across the forecasted period, with a market size of USD 6.5 million in 2025.
The Rest of the European Neonatal Intensive Care Respiratory Devices market is likely to achieve growth at a CAGR of 4% in the projection period, with a market size of USD 75.6 million in 2025.
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which APAC held the market share of around 24% of the global revenue with a market size of USD 447.1 million in 2025 and will evolve at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2033.
According to Cognitive Market Research, the China Neonatal Intensive Care Respiratory Devices market size was valued at USD 187.8 million in 2025 and is likely to expand at a CAGR of 8.4% during the projection timeframe. The neonatal intensive care respiratory devices market in China is surging due to expanding neonatal healthcare facilities and government-backed programs improving neonatal ICU accessibility.
The Japan Neonatal Intensive Care Respiratory Devices market is anticipated to witness growth at a CAGR of 7.4% within the calculated period, with a market size of USD 61.7 million in 2025.
The South Korean Neonatal Intensive Care Respiratory Devices market had a market share of USD 53.6 million in 2025 and is forecasted to grow at a CAGR of 8% during the calculated period.
The Indian Neonatal Intensive Care Respiratory Devices market is forecasted to show the fastest growth at a CAGR of 10.8% within the estimation period, with a market size of USD 44.7 million in 2025. The neonatal intensive care respiratory devices market in India is experiencing rapid expansion supported by rising medical tourism and increasing private sector participation in neonatal healthcare.
The Australian Neonatal Intensive Care Respiratory Devices market is anticipated to witness growth at a CAGR of 8.2% within the forecast horizon, with a market size of USD 23.2 million in 2025.
The Singapore Neonatal Intensive Care Respiratory Devices market is forecasted to witness growth at a CAGR of 9.2% across the anticipated period, with a market size of USD 8.9 million in 2025.
The Taiwan Neonatal Intensive Care Respiratory Devices market is projected to witness growth at a CAGR of 8.7% throughout the forecasting period, with a market size of USD 17.4 million in 2025.
The South East Asia Neonatal Intensive Care Respiratory Devices market is predicted to achieve growth at a CAGR of 9.7% over the forecast period, with a market size of USD 29.5 million in 2025.
The Rest of APAC Neonatal Intensive Care Respiratory Devices market is likely to undergo consistent growth at a CAGR of 8.7% over the analysis period, with a market size of USD 20.1 million in 2025.
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which South America held the market share of around 4% of the global revenue with a market size of USD 70.8 million in 2025 and will progress at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2033.
According to Cognitive Market Research, Brazil Neonatal Intensive Care Respiratory Devices market size was valued at USD 30.3 million in 2025 and is predicted to evolve at a CAGR of 7.5% during the projection timeframe. The neonatal intensive care respiratory devices market in Brazil is advancing due to improving neonatal healthcare coverage and growing awareness about early respiratory intervention in preterm infants.
Argentina Neonatal Intensive Care Respiratory Devices market had a market share of USD 11.9 million in 2025 and is projected to progress at a CAGR of 7.8% throughout the estimated timeframe. The demand for neonatal respiratory devices in Argentina is supported by improvements in healthcare accessibility and government healthcare programs focused on neonates.
Colombia Neonatal Intensive Care Respiratory Devices market is predicted to show moderate growth at a CAGR of 6.7% across the forecasted period, with a market size of USD 6.3 million in 2025.
Peru Neonatal Intensive Care Respiratory Devices market is projected to register gradual growth at a CAGR of 7.1% throughout the assessment period, with a market size of USD 5.8 million in 2025.
Chile Neonatal Intensive Care Respiratory Devices market is anticipated to witness growth at a CAGR of 7.2% throughout the forecasting period, with a market size of USD 5.1 million in 2025.
The Rest of South American Neonatal Intensive Care Respiratory Devices market is predicted to witness growth at a CAGR of 6% during the analysis period, with a market size of USD 11.4 million in 2025.
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which the Middle East held the market share of around 4% of the global revenue with a market size of USD 74.5 million in 2025 and will emerge at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033.
The Qatar Neonatal Intensive Care Respiratory Devices market is predicted to achieve growth at a CAGR of 7% during the assessment period, with a market size of USD 6 million in 2025.
The Saudi Arabia Neonatal Intensive Care Respiratory Devices market is forecasted to witness growth at a CAGR of 7.8% over the projection timeframe, with a market size of USD 26.2 million in 2025. The neonatal intensive care respiratory devices market in Saudi Arabia is expanding owing to Vision 2030 healthcare reforms and rising investments in advanced neonatal ventilation systems.
The Turkey Neonatal Intensive Care Respiratory Devices market is likely to register rapid growth at a CAGR of 8.1% throughout the forecast period, with a market size of USD 6 million in 2025. In Turkey, the increasing incidence of preterm births and the advancing healthcare infrastructure are supporting the rapid market growth of neonatal respiratory devices.
The UAE Neonatal Intensive Care Respiratory Devices market is projected to show moderate growth at a CAGR of 8% across the forecasted period, with a market size of USD 15.3 million in 2025.
The Egypt Neonatal Intensive Care Respiratory Devices market is predicted to undergo growth at a CAGR of 7.3% over the anticipated period, with a market size of USD 4.5 million in 2025.
The Rest of the Middle East Neonatal Intensive Care Respiratory Devices market is predicted to witness growth at a CAGR of 6.7% during the analysis period, with a market size of USD 16.5 million in 2025.
According to Cognitive Market Research, the global Neonatal Intensive Care Respiratory Devices market size was estimated at USD 1862.8 Million, out of which Africa held the market share of around 2% of the global revenue with a market size of USD 41 million in 2025 and will progress at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033.
The Nigeria Neonatal Intensive Care Respiratory Devices market is anticipated to register growth at a CAGR of 6.7% throughout the predicted period, with a market size of USD 3.3 million in 2025. In Nigeria, growth is attributed to improving neonatal healthcare initiatives and international collaborations to provide better respiratory care solutions for newborns.
The South African Neonatal Intensive Care Respiratory Devices market is estimated to witness growth at a CAGR of 7.4% within the forecast timeframe, with a market size of USD 14.4 million in 2025. In South Africa, an increasing number of preterm births and improved healthcare access in urban areas are supporting the growth of neonatal intensive-care respiratory devices.
The Rest of the African Neonatal Intensive Care Respiratory Devices market is predicted to observe growth at a CAGR of 5.7% across the estimated period, with a market size of USD 23.3 million in 2025.
Global Neonatal Intensive Care Respiratory Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Neonatal Intensive Care Respiratory Devices Industry growth. Neonatal Intensive Care Respiratory Devices market has been segmented with the help of its Device Type Outlook:, End-User Outlook: , and others. Neonatal Intensive Care Respiratory Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Neonatal Intensive Care Respiratory Devices Market?
According to Cognitive Market Research, the nebulizers category holds a dominant position within the global neonatal intensive care respiratory devices market share due to their critical role in delivering aerosolized medication directly to the lungs of premature and critically ill neonates. These devices are widely used in neonatal intensive care units (NICUs) to treat respiratory distress syndrome (RDS) and other pulmonary complications. The increasing incidence of neonatal respiratory disorders, coupled with innovations in nebulizer technology, such as vibrating mesh and ultrasonic nebulizers, has further strengthened their overall market presence.
Continuous positive airway pressure (CPAP) devices are emerging as the fastest-growing segment in the neonatal intensive care respiratory devices market, owing to their effectiveness in treating neonatal apnea, respiratory distress syndrome, and other breathing difficulties without the need for invasive ventilation. The rising preference for non-invasive respiratory support to reduce ventilator-associated complications and improve neonatal outcomes has promoted the demand for CPAP devices. Moreover, technological innovations, such as bubble CPAP and high-flow nasal CPAP systems, have enhanced their efficacy and comfort, making them an ideal choice in neonatal care settings.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Neonatal Intensive Care Respiratory Devices Industry. Request a Free Sample PDF!
According to Cognitive Market Research, neonatal intensive care unit (NICU) hospitals dominate the neonatal intensive care respiratory devices market due to their specialized infrastructure, modern medical technology, and skilled healthcare professionals dedicated to neonatal care. These hospitals are equipped with high-end respiratory support systems, including ventilators, nebulizers, and CPAP devices, which often ensure optimal treatment for premature and critically ill newborns. Moreover, the presence of multidisciplinary neonatal care teams and the availability of round-the-clock critical care services make NICU hospitals the primary choice for neonatal respiratory treatment.
Nursing homes are emerging as the fastest-growing category in the neonatal intensive care respiratory devices market, supported by the rising demand for decentralized and community-based neonatal care. These facilities provide intermediate care for newborns who require respiratory support but do not need intensive NICU interventions. Moreover, growing awareness about early neonatal care, government initiatives to expand maternal and child health services, and the rising trend of home-based neonatal care contribute to the rapid expansion of respiratory device adoption in nursing homes.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Analyst at Cognitive Market Research
Ankita Sharma is a passionate and detail-driven market research professional with over 2.5 years of experience in qualitative research. With a sharp focus on client query handling and competitive intelligence, she has successfully led and delivered impactful research projects across diverse industry verticals. At the core of Ankita’s work is her ability to transform complex market data into actionable insights. She has spearheaded market intelligence initiatives by analyzing trends, evaluating competitor strategies, and mapping evolving market dynamics using a range of industry tools. Her approach combines precision with adaptability ensuring research outcomes are tailored to client-specific needs and strategic goals.
Ankita is also skilled in secondary research and product benchmarking, offering a holistic view of competitive landscapes. Her collaborative spirit and cross-functional coordination have helped refine research methodologies and maintain the highest quality standards in deliverables. Ankita’s commitment to excellence and client success makes her a valuable asset in the evolving world of market intelligence and business strategy.
Ankita Sharma is a passionate and detail-driven market research professional with over 2.5 years of experience in qualitative research. With a sharp focus on client query handling and competitive intelligence, she has successfully led and delivered impactful research projects across diverse industry verticals. At the core of Ankita’s work is her ability to transform complex market data into actionable insights. She has spearheaded market intelligence initiatives by analyzing trends, evaluating competitor strategies, and mapping evolving market dynamics using a range of industry tools. Her approach combines precision with adaptability ensuring research outcomes are tailored to client-specific needs and strategic goals.
Ankita is also skilled in secondary research and product benchmarking, offering a holistic view of competitive landscapes. Her collaborative spirit and cross-functional coordination have helped refine research methodologies and maintain the highest quality standards in deliverables. Ankita’s commitment to excellence and client success makes her a valuable asset in the evolving world of market intelligence and business strategy.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
https://www.epa.gov/regulatory-information-sector/construction-sector-naics-23
https://www.usace.army.mil/Missions/Civil-Works/Engineering-and-Construction/
https://www.abs.gov.au/statistics/industry/building-and-construction
https://business.gov.au/planning/industry-information/construction-industry
https://www.usitc.gov/research_and_analysis/tradeshifts/2021/footwear
Disclaimer:
Device Type Outlook: | Nebulizers, Inhalers, Ventilators, CPAP Devices, Apnea Monitors, Others |
End-User Outlook: | NICU Hospitals, Specialty Clinics, Nursing Homes |
List of Competitors | Philips Healthcare (Netherlands), GE Healthcare (U.S.), Medtronic (Ireland), Drägerwerk AG & Co. KGaA (Germany), Hamilton Medical (Switzerland), Nihon Kohden Corporation (Japan), ResMed (U.S.), Smiths Group Plc (U.S.), Vyaire Medical (U.S.), Becton, Dickinson & Company (U.S.), Fisher & Paykel Healthcare (New Zealand), Getinge AB (Sweden), Inspiration Healthcare Group plc (U.K.), Allied Healthcare Products Inc. (U.S.), Acutronic Medical Systems AG (Switzerland) |
This chapter will help you gain GLOBAL Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review Global Neonatal Intensive Care Respiratory Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review North America Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review Europe Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review Asia Pacific Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review South America Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review Middle East Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Neonatal Intensive Care Respiratory Devices. Further deep in this chapter, you will be able to review Middle East Neonatal Intensive Care Respiratory Devices Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Neonatal Intensive Care Respiratory Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Device Type Outlook: Analysis 2019 -2031, will provide market size split by Device Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Device Type Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-User Outlook: Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Neonatal Intensive Care Respiratory Devices market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Nebulizers have a significant impact on Neonatal Intensive Care Respiratory Devices market? |
What are the key factors affecting the Nebulizers and Inhalers of Neonatal Intensive Care Respiratory Devices Market? |
What is the CAGR/Growth Rate of NICU Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Neonatal Intensive Care Respiratory Devices Market? |
Which region is expected to dominate the global Neonatal Intensive Care Respiratory Devices Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|